Fingolimod Capsules
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-26-R-0007
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical intends to solicit a national requirements contract for Fingolimod 0.5MG capsules in 30-count bottles with a projected solicitation release in April 2026. This is an unrestricted, fully competitive acquisition with no set-aside; all sources may submit proposals. The contract will be firm-fixed price, requirements type, with a one-year base period and four one-year options. Performance supports multiple federal customers—Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons—through DLA and VA prime vendor programs. Annual usage estimates will appear in the Schedule of Supplies section of the solicitation. As a commercial item, the procurement is governed by FAR part 12. The solicitation will be posted to DIBBS at https://www.dibbs.bsm.dla.mil and to SAM.gov. Interested parties should contact Henry Shelly at (267) 453-0756 or henry.shelly@dla.mil with questions or to set up automated notifications of pre-solicitation and solicitation changes. DLA reserves the right to issue the solicitation before or after the projected April 2026 date.
Notice text
The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Fingolimod Capsules. Procurement details follow.
Fingolimod 0.5MG capsules in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Henry Shelly at (267) 453-0756 or henry.shelly@dla.mil with any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Fingolimod Capsules | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity